Recurrent Ovarian Low Grade Endometrioid Adenocarcinoma
specificThe reemergence of ovarian low-grade endometrioid adenocarcinoma after a period of remission.
9
Centers
9
Active Trials
—
Cancer Funding
Top Centers for Recurrent Ovarian Low Grade Endometrioid Adenocarcinoma(9)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 55.6 |
| 2 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 55.6 |
| 3 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 55.6 |
| 4 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 55.6 |
| 5 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 55.6 |
| 6 | University of Illinois Cancer CenterChicago, IL Active Research Program | 55.6 |
| 7 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 55.6 |
| 8 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 55.6 |
| 9 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 55.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →